To ensure that the drug or physiological saline solution reaches the site of action, it is nebulised into tiny droplets: the aerosol.
The substances can then be directly absorbed via the mucous membranes of the upper or lower airways. Where they actually arrive and how they work depends on factors such as their size.
The larger droplets are already absorbed within the upper airways: in the mouth or throat, the larynx or the nose, depending on the nebuliser system used.
Smaller droplets on the other hand are able to reach the lower airways.
For targeted treatment of the lower airways it is important to use a droplet spectrum which is suited to the age group of the patient and the required target area in the body. In children and infants for example, the airways are not as wide and call for a finer droplet spectrum than the airway tracts of adults.
Some drugs should ideally be directed to the peripheral areas of the lung, while others need to be deposited centrally.
The PARI LC SPRINT Nebulisers are equipped with various nozzle inserts designed to produce different droplet spectrums and represent a solution that caters to the individual needs of each patient.
The ideal nozzle insert for efficient deposition in the central area of the lung for older children and adults, with very short inhalation times. Included in the PARI LC SPRINT Nebuliser.
Is included in the PARI LC SPRINT Junior Nebuliser and delivers aerosol for efficient deposition in the airways of babies and infants.
Tiny droplets for the peripheral area of the lung, or for babies (premature infants upwards).
Included in the PARI LC SPRINT BABY Nebuliser and the PARI LC SPRINT STAR Nebuliser. Designed specifically to reach the finest structures of the lung.
As a component of the PARI LC SPRINT SINUS nebuliser the nozzle attachment provides an ideal aerosol spectrum for the efficient deposition in the paranasal sinuses.